RxDoctor Payments Data

Timothy Daugherty, MD

Plastic and Reconstructive Surgery · Springfield, ILNPI 1780066738

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $15,875 of the $20,508 with a category attached, or 77.4%. Axogen accounts for 94.7% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $19,533, more than ten times the $201 reported in 2019.

$20,508in general payments, 2019–2025

Across 42 payments — averaging $488.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axogen$19K
  • Checkpoint Surgical, Inc$282
  • Endo Pharmaceuticals Inc.$272
  • Johnson & Johnson$167
  • Integra Lifesciences Corporation$121
  • Trimed, Inc.$112
  • plus $133 from 4 others

What the payments were for

  • Consulting fees$15,87577%
  • Speaking & faculty fees$500%
  • Travel & lodging$1,7519%
  • Food & beverage$2,83114%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,508 in reported general payments places this provider in the 85th percentile of 126 plastic and reconstructive surgery providers in Illinois.

See all plastic and reconstructive surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$65,274
Medicare patients
105
Services billed
738

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl13$46

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Springfield

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →